A comprehensive review of neurologic manifestations of COVID-19 and management of pre-existing neurologic disorders in children Y Kim, SA Walser, SJ Asghar, R Jain, G Mainali, A Kumar Journal of child neurology 36 (4), 324-330, 2021 | 43 | 2021 |
The roles of iron and HFE genotype in neurological diseases Y Kim, JR Connor Molecular Aspects of Medicine 75, 100867, 2020 | 35 | 2020 |
The Nrf2-mediated defense mechanism associated with HFE genotype limits vulnerability to oxidative stress-induced toxicity IY Song, AM Snyder, Y Kim, EB Neely, QW Wade, JR Connor Toxicology 441, 152525, 2020 | 16 | 2020 |
H63D variant of the homeostatic iron regulator (HFE) gene alters α‐synuclein expression, aggregation, and toxicity Y Kim, MC Stahl, X Huang, JR Connor Journal of neurochemistry 155 (2), 177-190, 2020 | 14 | 2020 |
A pediatric case of sensory predominant Guillain-Barré syndrome following COVID-19 vaccination Y Kim, Z Zhu, P Kochar, P Gavigan, D Kaur, A Kumar Child neurology open 9, 2329048X221074549, 2022 | 10 | 2022 |
A comprehensive review of neuromuscular manifestations of covid-19 and management of pre-existing neuromuscular disorders in children DJ Goetschius, Y Kim, A Kumar, D Paul, S Naik Journal of clinical medicine 11 (4), 934, 2022 | 7 | 2022 |
Recurrent Superior Vena Cava Syndrome in a Patient with Sarcoidosis and Pancreatic Adenocarcinoma: A Case Report and Literature Review G Shenoy, Y Kim, K Newmaster, KL McGillen, F Ruggiero, NS Yee Medicines 7 (9), 56, 2020 | 1 | 2020 |
Alpha-synuclein protein homeostasis and oligomerization in iron-overloaded cells expressing mutant HFE (P3. 059) Y Kim, J Connor, M Stahl Neurology 90 (15_supplement), P3. 059, 2018 | 1 | 2018 |
H63D Hfe as a Genetic Modifier of Parkinson’s Disease: Clinical Impacts and Molecular Mechanisms Y Kim The Pennsylvania State University, 2020 | | 2020 |